
Blood and saliva tests that can help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients, have been developed by physicians at Johns Hopkins. The tests screen for DNA fragments of the human papillomavirus (HPV) shed from cancer cells lingering in the mouth or other parts of the body. A description of the development is published in the July 31 issue of emJAMA Otolaryngology - Head (and) Neck Surgery/em. "There is a window ...
Read More
No comments:
Post a Comment